课题基金 / 基金详情

Modular Subunit Vaccine for Salmonella

Modular Subunit Vaccine for Salmonella
沙门氏菌模块化亚单位疫苗
批准号:
7092457
负责人:
Marc Kevin Jenkins
金额:
$23.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-01 至 2011-04-30

项目摘要

项目成果

Marc Kevin Jenkins的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):沙门氏菌种类每年导致数百万摄入受污染食物或水的人患病或死亡。在沙门氏菌感染中幸存下来的人产生了强大的免疫力,这种免疫力依赖于促进巨噬细胞吞噬细菌的抗体,以及刺激巨噬细胞杀死吞噬细菌的CD4+T细胞的淋巴因子。出于实际原因,需要一种能够诱导免疫水平的亚单位疫苗,这种水平可以由活的生物体诱导。不幸的是,单独的沙门氏菌蛋白免疫通常只能诱导部分免疫。该项目的长期目标是克服这种低效,并生产出一种有效的沙门氏菌亚单位疫苗。我们的假设是,个别沙门氏菌蛋白的保护作用低于减毒生物,因为在感染过程中始终缺乏呈现,固有的弱佐剂活性,以及难以进入粘膜淋巴器官。我们的具体目标是生产一种单一的疫苗来解决这些弱点。我们建议从鼠伤寒沙门氏菌蛋白中鉴定免疫优势肽,在鼠伤寒沙门氏菌感染后早期和晚期激活CD4+T细胞。这些多肽将与鼠伤寒沙门氏菌的Toll样受体5结合部分(作为佐剂并包含B细胞表位)和假结核耶尔森菌的β1整合素结合域(促进M细胞将颗粒转移到Peyer‘s斑块)一起整合到颗粒中。含有所有这些成分的颗粒将被测试产生对沙门氏菌的保护性免疫的能力,并将使用跟踪多肽的新方法:MHC II复合体、特定的CD4+T细胞和抗体来评估负责免疫的细胞机制。这些目标的完成将为沙门氏菌、其他感染源和癌症的有效亚单位疫苗的合理设计提供一个框架。
英文摘要
DESCRIPTION (provided by applicant): Salmonella species cause disease or death in millions of individuals every year who ingest contaminated food or water. Individuals who survive Salmonella infection develop robust immunity that is dependent on antibodies that facilitate bacterial phagocytosis by macrophages, and lymphokines from CD4+ T cells that stimulate macrophages to kill engulfed bacteria. For practical reasons, a subunit vaccine capable of inducing the level of immunity that can be induced by live organisms, is desirable. Unfortunately, immunization with individual Salmonella proteins usually induces only partial immunity. The long-term goal of this project is to overcome this inefficiency and produce an effective subunit vaccine for Salmonella. Our hypothesis is that individual Salmonella proteins are less protective than attenuated organisms because of a lack of presentation at all times during infection, inherently weak adjuvant activity, and poor entry into the mucosal lymphoid organs. Our specific aim is to produce a single vaccine that addresses each of these weaknesses. We propose to identify immunodominant peptides from S. typhimurium proteins that activate CD4+ T cells early and late after S. typhimurium infection. These peptides will be incorporated into particles along with the Toll-like receptor 5-binding portion of S. typhimurium FliC, which functions as an adjuvant and contains B cell epitopes, and the beta 1 integrin-binding domain of Yersinia pseudotuberculosis, which facilitates M cell translocation of particles into the Peyer's patches. The particles containing all of these components will be tested for the ability to generate protective immunity to Salmonella, and novel methods to track peptide:MHC II complexes, specific CD4+ T cells, and antibodies will be employed to assess the cellular mechanisms responsible for immunity. Completion of these aims will provide a framework for the rational design of effective subunit vaccines for Salmonella, other infectious agents, and cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Detection and Activation of CD4+ T cells with Low Affinity TCRs
  • 批准号:
    10348758
  • 项目类别:
  • 资助金额:
    $38.32万
  • 财政年份:
    2019
  • 负责人:
    Marc Kevin Jenkins
  • 依托单位:
Detection and Activation of CD4+ T cells with Low Affinity TCRs
  • 批准号:
    10570243
  • 项目类别:
  • 资助金额:
    $38.32万
  • 财政年份:
    2019
  • 负责人:
    Marc Kevin Jenkins
  • 依托单位:
Protective CD4+ T Cells
  • 批准号:
    10349513
  • 项目类别:
  • 资助金额:
    $46.74万
  • 财政年份:
    2013
  • 负责人:
    Marc Kevin Jenkins
  • 依托单位:
Protective CD4+ T cells
  • 批准号:
    8430702
  • 项目类别:
  • 资助金额:
    $35.72万
  • 财政年份:
    2013
  • 负责人:
    Marc Kevin Jenkins
  • 依托单位:
国内基金
海外基金
CD8+T细胞亚群在抗MDA5抗体阳性皮肌炎中的致病机制研究
  • 批准号:
    82371805
  • 项目类别:
    面上项目
  • 资助金额:
    45.00万元
  • 批准年份:
    2023
  • 负责人:
    扶琼
  • 依托单位:
沙眼衣原体pORF5蛋白功能及其与宿主细胞相互作用的研究
  • 批准号:
    30970165
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2009
  • 负责人:
    李忠玉
  • 依托单位: